MOORESTOWN, N.J., Oct. 22, 2018 — Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, is participating in the 2018 NPA (National PACE Association) conference being held in Portland, OR, October 21-24, 2018.
“The NPA Annual Conference is a great opportunity for us to spend time with our PACE clients from around the country,” stated TRHC President Orsula V. Knowlton, PharmD, MBA. “We educate, we learn, we enjoy networking and return to our respective work energized to do even more to assure medication safety and better healthcare outcomes.”
PACE is the federal Program of All-Inclusive Care for the Elderly, a Medicare and Medicaid benefit for individuals 55 and older who are nursing home eligible. The goal of the program is to keep participants living in their own homes while receiving quality care. PACE organizations nationwide rely on TRHC technology, science, and pharmacists who are board certified in geriatrics to improve medication safety, improve adherence, and reduce participant hospitalizations.
TRHC hosted a PACE education and networking event, Portland Uncorked!, Sunday, October 21, at which TRHC Chairman and CEO, Calvin H. Knowlton, PhD, unveiled the recently launched TRHC division CareVention HealthCare. According to Dr. Knowlton, “With this PACE platform our goal is to help our clients compete on analytics.” CareVention HealthCare was created to help optimize care and in response to NPA’s PACE 2.0, an initiative to accelerate PACE growth. CareVention HealthCare will offer integrated platform technology for PACE organizations, including data analytics, consulting, and other services for PACE.
At the NPA conference, team members from TRHC subsidiary companies, CareKinesis and Capstone Performance Systems, will participate in the following Educational Sessions:
Polypharmacy – How to Reduce Medication Risk
Pharmacy Topics: Clinical Topics
Using Novel Risk Stratification and a System for Medication Risk Scoring of PACE Participants to Reduce Preventable Adverse Drug Events
The CMS 1/3 Financial Audits are Changing – Are you Adapting?
For TRHC, another Conference highlight will be the recognition of Richard Schamp, MD, CEO Emeritus of Capstone Performance Systems, for his significant contributions to PACE over the years. Dr. Schamp will continue in his role as Chief Medical Officer for Tabula Rasa HealthCare.
About Tabula Rasa HealthCare
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize patient outcomes, lower healthcare costs, and improve organizational performance. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 14, 2018, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
Bob East or Asher Dewhurst
T: (443) 213-0500